Chemotherapy and biotherapy in the treatment of neuroendocrine tumours

Annals of Oncology

Volumn 12, Issue SUPPLE. 2, 2001, Pages

  Oberg K ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alpha interferon; Lanreotide; Octreotide; Somatostatin analogues; Streptozotocin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOPEPTIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; LONG ACTING DRUG; OCTREOTIDE; PARACETAMOL; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; STREPTOZOCIN;

ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTIFICIAL EMBOLISM; AUTOIMMUNITY; BINDING AFFINITY; CARCINOID; CARCINOID SYNDROME; CHEMOTHERAPY; CHRONIC FATIGUE SYNDROME; DEPRESSION; DOSE RESPONSE; DRUG FORMULATION; DRUG RECEPTOR BINDING; ENDOCRINE TUMOR; FLU LIKE SYNDROME; GASTROINTESTINAL TUMOR; HUMAN; INTESTINE TUMOR; LUNG TUMOR; MIDGUT; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SURVIVAL; THYROID DISEASE; TUMOR GROWTH; TUMOR REGRESSION;

EID: 0035167563     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_2.s111     Document Type: Review

References (23)

1. Carcinoid tumors: An analysis of 2837 cases
2. Treatment of the carcinoid tumor and the malignant carcinoid syndrome
3. Streptozocin-doxorubicin, streptozocin fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma
4. An update of the medical treatment of malignant endocrine pancreatic tumors
5. The use of chemotherapy in the management of neuroendocrine tumours
6. Cytotoxic treatment in patients with malignant carcinoid tumors: Response to streptozocin - Alone or in combination with 5-FU
7. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome
8. Treatment of neuro-endocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
9. Effective palliative treatment of metastatic carcinoid tumours with intra-arterial chemotherapy/chemoembolisation combined with octreotide acetate
10. A study of biological behaviour based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system
11. Typical and atypical bronchopulmonary carcinoid tumors: A clinico-pathologic and Ki-67 labeling study
12. Effects of leukocyte interferon upon clinical symptoms and hormone levels in patients with midgut carcinoid tumors and the carcinoid syndrome
13. Treatment of malignant carcinoid tumors with human leukocyte interferon. Long-term results
14. Recombinant interferon alpha 2b in patients with metastatic apudomas; effect on tumors and tumor markers
15. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon
16. The effect of interferon α-2b treatment with or without prior hepatic artery embolization on clinical response and survival in midgut carcinoid patients
17. The role of interferons in the management of carcinoid tumors
18. Octreotide and interferon alpha: A new combination for the treatment of malignant carcinoid tumors
19. Antiproliferative treatment of metastatic neuroendocrine gastro-enteropancreatic tumors; effect of combination therapy with octreotide and α-interferon
20. Mini-review: The somatostatin receptor family
21. Octreotide treatment of carcinoid syndrome: Analysis of published dose-titration data
22. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs
23. Efficacy and safety of lanreotide prolonged release in patients with gastrointestinal neuroendocrine tumors with hormone related symptoms